Oxford BioMedica PLC
OTC:OXBDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oxford BioMedica PLC
OTC:OXBDF
|
UK |
|
A
|
Amex Exploration Inc
SWB:MX0
|
CA |
|
CreditRiskMonitor.Com Inc
OTC:CRMZ
|
US |
|
B
|
Brightcove Inc
F:2BV
|
US |
|
K
|
Kiwetinohk Energy Corp
F:Y9B
|
CA |
|
EGPI Firecreek Inc
OTC:EFIR
|
US |
|
E
|
Emerging World Pharma Inc
OTC:EWPI
|
US |
|
P
|
Pool Safe Inc
OTC:PFFEF
|
CA |
|
Solocal Group SA
F:QS3
|
FR |
|
E
|
Evergreen Sustainable Enterprises Inc
OTC:EGSE
|
US |
|
F
|
Favo Capital Inc
OTC:FAVO
|
US |
|
EPIC Corp
OTC:EPOR
|
US |
|
C
|
Canyon Bancorp
OTC:CYBA
|
US |
|
Enertopia Corp
OTC:ENRT
|
CA |
|
C
|
Cornerstone Bancorp Inc
OTC:CNBP
|
US |
|
China Sun Group High-Tech Co
OTC:CSGH
|
CN |
|
P
|
Philomaxcap AG
DUS:HBD1
|
DE |
|
A
|
ALBA SE
XMUN:ABA
|
DE |
|
E
|
eFotoXpress Inc
OTC:EFOT
|
US |
|
D
|
Dimeco Inc
OTC:DIMC
|
US |
|
E
|
ECGI Holdings Inc
OTC:ECGI
|
CA |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
CO |
|
American Green Inc
OTC:ERBB
|
US |
Bankruptcy Probability
Oxford BioMedica PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oxford BioMedica PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Oxford BioMedica PLC
LSE:OXB
|
612.2m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
470B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oxford BioMedica PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oxford BioMedica PLC has total debt of 142.1m GBP. This includes both short-term (0 GBP) and long-term (142.1m GBP) debt.
You can find a full breakdown on its Balance Sheet.
